---
title: Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy
description: "IO Summit 2022 Poster: Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy"
image: https://resources.huborganoids.nl/hubfs/io-summit22-poster-autoglass-organoids.jpg
---

[![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

# Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy

![ELRIG 2022 Poster](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/io-summit-autologous-organoids-and-T-cell-co-cultures.png?width=300&name=io-summit-autologous-organoids-and-T-cell-co-cultures.png)

Cancer immunotherapies have shown substantial success as a treatment strategy to combat cancer. However, their efficacy is limited to only a subset of patients. Treatment failure can be attributed to the high degree of heterogeneity in patient tumors and immunosuppressive tumor features, which are both critical aspects that need to be recapitulated in preclinical models used for the development of novel immunotherapeutics.

#### Download this poster to discover:

- How autologous HUB Organoids® T cell co-cultures serve as a patient-relevant *in vitro* platform to test effective immunotherapies
- Our protocols for generating biobanks of both normal and colorectal cancer (CRC) organoids paired with tumor-infiltrating lymphocytes (TILs)
- How to enrich your culture for tumor-reactive TILs and their application to tumor-specific killing

### Download our poster

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*